Should Treatment of Mesothelioma Include Surgery? MARS2 Fails to Land.
무작위 임상시험
1/5 보강
The presentation of the Mesothelioma and Radical Surgery 2 trial, a randomized controlled trial comparing pleurectomy/decortication to no surgery, injected new data into the contentious discussion sur
- 연구 설계 randomized controlled trial
APA
Gulati S, Wolf AS, Flores RM (2026). Should Treatment of Mesothelioma Include Surgery? MARS2 Fails to Land.. Seminars in thoracic and cardiovascular surgery, 38(1), 67-70. https://doi.org/10.1053/j.semtcvs.2024.07.001
MLA
Gulati S, et al.. "Should Treatment of Mesothelioma Include Surgery? MARS2 Fails to Land.." Seminars in thoracic and cardiovascular surgery, vol. 38, no. 1, 2026, pp. 67-70.
PMID
39029604 ↗
Abstract 한글 요약
The presentation of the Mesothelioma and Radical Surgery 2 trial, a randomized controlled trial comparing pleurectomy/decortication to no surgery, injected new data into the contentious discussion surrounding the use of surgery in the management of diffuse pleural mesothelioma. We review the trial results in the context of the existing work surrounding the use of surgery in pleural mesothelioma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.